Global prevalence of nocturnal hypertension: systematic review and meta-analysis
Abstract
Background: Nighttime blood pressure (BP) is a stronger predictor of cardiovascular events than daytime BP. However, the global prevalence of nocturnal hypertension across different populations has not been previously described. This review estimates the global prevalence of nocturnal hypertension, offering insights to guide clinical practice, healthcare planning and future research.
Methods: For this systematic review and meta-analysis, we searched PubMed, EMBASE, CINAHL, and Scopus and included studies reporting the prevalence of nocturnal hypertension and non-dipping BP in adults, including studies published up to 12 December 2024. Study selection, data extraction, and risk of bias assessment were conducted independently by two reviewers, with discrepancies resolved by consensus. There were no language restrictions. Random-effects meta-analyses were used to estimate pooled prevalence across study populations. The review was pre-registered with PROSPERO (CRD42025625712).
Results: A total of 449 studies were included. The prevalence of nocturnal hypertension was 45% (95% confidence interval (CI): 39-51, I2=97.4%) in the general population and was higher among individuals with hypertension (57%, 95%CI: 54-60, I2=84.7%), and high-risk patients including diabetes mellitus (56%, 95%CI: 38-72, I2=97.1%), obstructive sleep apnoea (60%, 95%CI: 42-78, I2=93.0%), chronic kidney disease (64%, 95%CI: 53-73, I2=95.2%). The prevalence of isolated nocturnal hypertension in the general…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Evaluating the Evidence Base of Melatonin, Light Exposure, Exercise, and Complementary and Alternative Medicine for Patients with Insomnia Disorder
- Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
- Influence of evening light exposure on polysomnographically assessed night-time sleep: A systematic review with meta-analysis
- Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
- Significant potential of melatonin therapy in Parkinson’s disease – a meta-analysis of randomized controlled trials
- Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.